Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
Researchers from Abertay University in the UK have grown mini beating human hearts in which they can induce heart disease, allowing them to test newly created drugs.
Increasing the feeling of being full by eating more fruits and vegetables is not an effective diet recommendation, according to a new systematic review.
A new study examines Spanish appropriateness criteria for total knee replacement surgery, in response to concerns that the surgery has become overused in the US.